Achilles therapeutics reports first quarter 2023 financial results and recent business highlights

- phase i/iia clinical trials in nsclc and melanoma progressing with additional clinical and translational science data expected in the fourth quarter of 2023 -

ACHL Ratings Summary

ACHL Quant Ranking